CD8A and Huntington disease: Furthermore, SARS-CoV-2 specific-IFN-γ-producing CD8+ and CD4+ T-cell responses were detected in 35 and 36/37 of HD patients, respectively, indicating that mRNA COVID-19 vaccines induce a booster effect on both humoral and cellular immune responses in this immunocompromised group [12].